XIFAXAN is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cardinal Health. The primary component is Rifaximin.
| Product ID | 55154-6777_08ea4212-5126-48c4-8cb5-3ec2f57601ba |
| NDC | 55154-6777 |
| Product Type | Human Prescription Drug |
| Proprietary Name | XIFAXAN |
| Generic Name | Rifaximin |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-05-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021361 |
| Labeler Name | Cardinal Health |
| Substance Name | RIFAXIMIN |
| Active Ingredient Strength | 550 mg/1 |
| Pharm Classes | Rifamycin Antibacterial [EPC],Rifamycins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2010-05-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021361 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2010-05-01 |
| Ingredient | Strength |
|---|---|
| RIFAXIMIN | 550 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50090-2445 | XIFAXAN | rifaximin |
| 55154-6777 | XIFAXAN | rifaximin |
| 65649-301 | XIFAXAN | rifaximin |
| 65649-303 | XIFAXAN | rifaximin |
| 68151-4980 | XIFAXAN | rifaximin |
| 68258-1107 | XIFAXAN | RIFAXIMIN |
| 69189-0309 | XIFAXAN | rifaximin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() XIFAXAN 78428755 2965332 Live/Registered |
ALFASIGMA S.P.A. 2004-06-02 |